Teladoc health, inc. (TDOC)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Revenue

553,307

417,907

233,279

123,157

77,384

43,528

19,906

Expenses:
Cost of revenue (exclusive of depreciation and amortization shown separately below)

184,465

128,735

61,623

31,971

21,041

9,929

4,186

Gross profit

-

-

-

91,186

56,343

33,599

15,720

Operating expenses:
Advertising and marketing

109,697

85,109

57,663

34,720

20,236

7,662

4,090

Sales

64,915

59,154

37,984

26,243

17,976

11,571

4,441

Technology and development

64,644

54,373

34,459

21,815

14,210

7,573

3,532

Legal and regulatory

6,762

3,981

4,872

-

-

-

-

Legal

-

-

-

4,117

8,878

1,311

-

Regulatory

-

-

-

3,158

2,433

429

-

Acquisition and integration related costs

6,620

10,391

13,196

6,959

551

196

-

Gain on sale

0

5,500

0

-

-

-

-

General and administrative

157,694

116,916

79,781

48,568

42,981

17,687

8,772

Depreciation and amortization

38,952

35,602

19,095

8,270

4,863

2,320

754

Total expenses

633,749

488,761

308,673

-

-

-

-

Loss from operations

-80,442

-70,854

-75,394

-62,664

-55,785

-15,150

-5,869

Amortization of warrants and loss on extinguishment of debt

0

0

14,122

8,454

-

-

-

Interest expense, net

-29,013

-26,112

-17,491

-2,588

-2,199

-1,499

-56

Net loss before taxes

-109,455

-96,966

-107,007

-73,706

-57,984

-16,649

-5,925

Income tax (benefit) expense

-10,591

118

-225

510

36

388

94

Net loss

-98,864

-97,084

-106,782

-74,216

-58,020

-17,037

-6,019

Net loss per share, basic and diluted

-1.38

-1.47

-1.93

-1.75

-2.91

-10.25

-8.05

Weighted-average shares used to compute basic and diluted net loss per share

71,845

65,845

55,427

42,330

19,917

1,962

1,222